Speakers

“Hyperthyroid guideline update”

Douglas Ross is a Professor of Medicine at Harvard Medical School and Co-Director of the Massachusetts General Hospital Thyroid Clinic. He received an undergraduate degree in Life Sciences, and a master’s degree in Nutritional Biochemistry and Metabolism from the Massachusetts Institute of Technology, and his medical degree from Harvard Medical School. He completed his residency in internal medicine and his fellowship in endocrinology at the Massachusetts General Hospital. He is Thyroid Section Editor of UpToDate, and serves on the editorial board on Thyroid. He has previously been on the editorial board of the Journal of Clinical Endocrinology and Metabolism. He served as a member (2011) and chair (2016) of the American Thyroid Association’s Hyperthyroidism Guidelines Task Force. He was a member of the National Thyroid Cancer Treatment Cooperative Study Group where he focused on outcomes of patients with papillary microcarcinoma.

MINGZHAO XING, MD, PhD

JOHNS HOPKINS MEDICINE

DOUGLAS ROSS, MD

MASSACHUSETTS GENERAL HOSPITAL

ELIZABETH PEARCE, MD, MSc

BOSTON UNIVERSITY SCHOOL OF MEDICINE

Mingzhao Xing, M.D., Ph.D., is tenured Professor of Medicine, Oncology, Pathology, and Cellular & Molecular Medicine, Director of the Thyroid Tumor Center, and Chief of the Laboratory for Cellular and Molecular Thyroid Research at the Johns Hopkins University School of Medicine. He previously received medical training at the Second Military Medical University in Shanghai, China and Ph D training at Case Western Reserve University in Cleveland, Ohio, USA. He received medical residency training at Greater Baltimore Medical Center and clinical endocrinology fellowship training at Johns Hopkins Hospital in Baltimore, Maryland, USA. American board-certified in Internal Medicine and Endocrinology & Metabolism, for the last 16 years, Dr, Xing has been working at Johns Hopkins Hospital as an endocrine

“Predictive value of thyroid mutations for prognosis and treatment selection”

“Thyroid in pregnancy guidelines”

Elizabeth Pearce, MD, MSc received her undergraduate and medical degrees from Harvard and a masters' degree in epidemiology from the Boston University School of Public Health. She completed her residency in internal medicine at Beth Israel Deaconess Medical Center, and her fellowship in endocrinology at the Boston University Medical Center.

She is currently an Associate Professor of Medicine at Boston University School of Medicine in the Section of Endocrinology, Diabetes, and Nutrition. She has served on the editorial boards for Endocrine Practice, Thyroid, the Journal of Clinical Endocrinology and Metabolism, the European Journal of Clinical Nutrition, and Lancet Diabetes & Endocrinology. She has served as a member of

subspecialty consultant and teaching attending while directing a thyroid research program as a physician scientist there. His main clinical and research interests are in thyroid diseases, particularly thyroid tumor. Supported by the American Cancer Society and NIH R0-1 grants, his laboratory has been studying molecular, genetic, and epigenetic mechanisms of thyroid cancer and their clinical translation. He has nearly 150 publications in various prestigious journals, such as JCEM, Clinical Cancer Research, Cancer Research, Journal of Clinical Investigation, JNCI, Journal of Clinical Oncology, JAMA Oncology, Lancet, JAMA, Nature Reviews Cancer, and Endocrine Reviews. He holds/co-holds five USA patents on such thyroid research contributions as initial discovery and clinical characterization of the BRAF V600E and TERT promoter mutations in thyroid cancer and initial demonstration of targeting BRAF/MEK to restore thyroid gene expression and radioiodine uptake for radioiodine treatment of thyroid cancer. His work is consistently among world’s top 1% citations in the thyroid field (received >10,000 citations) in recent years, which brought him the 2006 Maryland Innovator Award, the 2013 British Endocrine Society’s Endocrine-Related Cancer Research Award, the 2014 Chinese Endocrine Society’s Zhu Xianyi (朱宪彝) Award, and the 2016 American Thyroid Association’s Paul Starr Award. He has been recognized among the “World’s Top 10 Thyroid Cancer Experts” by Expertscape and “America’s Top Doctors” by US News & World Reports and other professional recognition entities. He has served several leadership roles at the American Thyroid Association, including the Research Committee Chair, Associate Editor of the journal Thyroid, and Co-Chair of the 2016-2017 ATA Annual Meeting Program Committee.

the board of directors of the American Thyroid Association and is currently on the management council of the International Council for the Control of Iodine Deficiency Disorders. She recently served as a member of the American Thyroid Association's Thyroid in Pregnancy Guidelines Task Force. Her research interests include the sufficiency of dietary iodine in the U.S., thyroid function in pregnancy, the thyroid effects of environmental perchlorate exposure, and the cardiovascular effects of subclinical thyroid dysfunction. Dr. Pearce was the 2011 recipient of the American Thyroid Association's Van Meter Award for outstanding contributions to research on the thyroid gland.